Aidea Pharma(SH:688488) Zheng Quan Zhi Xing·2025-06-27 16:50General Information - Jiangsu Aidea Pharmaceutical Co., Ltd. was established as a joint-stock company based on the transformation of a limited liability company, registered in Yangzhou, Jiangsu Province with a unified social credit code of 913210006979433664 [1] - The company was approved by the Shanghai Stock Exchange on June 1, 2020, and registered by the China Securities Regulatory Commission on June 18, 2020, issuing 60 million shares of RMB ordinary stock, and was listed on the Sci-Tech Innovation Board on July 20, 2020 [1][3] Company Structure - The registered capital of the company is RMB 420.782808 million [2] - The company is a permanent stock company, with all assets divided into equal shares, and shareholders are liable for the company's debts only to the extent of their subscribed shares [2][3] - The chairman of the board represents the company in executing its affairs and is the legal representative [2] Business Objectives and Scope - The company's business objective is to leverage the strengths of its joint venture partners to develop the biopharmaceutical business, providing high-quality products and creating economic and social benefits to return to shareholders and society [3] - The approved business scope includes drug research and development, production and sales, development and processing of effective components from animal organs and plant materials, and technology research and transfer [3][4] Share Issuance and Management - The company's shares are issued in the form of stocks, with each share having a par value of RMB 1.00 [4] - The total number of shares issued by the company is 420.782808 million, all of which are ordinary shares [5] - The company cannot repurchase its own shares except under specific circumstances, such as dissenting shareholders requesting buybacks due to merger resolutions [7][8] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, participate in shareholder meetings, supervise company operations, and access company documents [11][12] - Shareholders holding more than 5% of voting shares must report any pledges of their shares to the company [15][16] - The company must ensure that shareholders do not abuse their rights to harm the company or other shareholders [15][16] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting occurring once a year [22] - Shareholders holding more than 10% of shares can request a temporary meeting [23] - The company must provide adequate notice and details about the meeting, including the agenda and voting procedures [27][28]